An initial audit of the treatment of patients presenting to the GUM Department at Leeds
General Infirmary with a first episode of anogenital warts was reported in 1993. Treatment …

Objectives To estimate the total number of cases of, and cost of care for, genital warts (GWs)
in England, to inform economic evaluations of human papillomavirus vaccination. Methods …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Home treatment with podophyllotoxin or imiquimod are commonly prescribed therapies for
anogenital warts. It is important to ascertain if patients are locating all lesions for treatment …

The prevalence of genital warts (GW) and self-reported human papillomavirus (HPV) as well
as disease-related psychosocial impact among male and female patients aged 18–60 years …

OBJECTIVE: To examine information giving by genitourinary medicine (GUM) consultants
about the use of condoms for patients with anogenital warts (AGW). METHOD: 228 GUM …

Background. Warts are cutaneous and, sometimes, mucosal lesions caused by one of the
several human papilloma viruses. Aim. Assessment of the clinicoepidemiological aspects of …

Background Condyloma acuminata currently affects around 1% of sexually active adults,
and its incidence is increasing. The coexistence of genital warts (GW) and certain cancers …

To determine the prevalence of anogenital warts (AGWs) and concurrent sexually
transmitted infections (STIs) in men who have sex with men (MSM), and their knowledge of …

Background. Human papillomavirus (HPV) causes a spectrum of disease, ranging from
warts to cancer. Prevalence, incidence, and factors associated with anogenital warts in East …